Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia

By Avi Radko   Huik Kristi   Pauskar Merit   Ustina Valentina   Karki Tonis   Krispin Tonu   Ainsalu Külliki   Paap Piret   Schmidt Jelena   Nikitina Natalia   Lutsar Irja  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 2, 2011-02 ,pp. : 122-128

Informa Healthcare

Access to resources Recommend Favorite

Factors Influencing the Development of Lipodystrophy in Human Immunodeficiency Virus-infected Patients

By Collazos Julio   Rodriguez-guardado Azucena   Maradona Jose A.   Mayo Jose   Asensi Victor   Ibarra Sofía   Carton Jose A.   Casado Luis  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 5, 2003-01 ,pp. : 339-340

Informa Healthcare

Access to resources Recommend Favorite

Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 2063-2071

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review

By Kim Tark  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 6, 2013-06 ,pp. : 484-488

Informa Healthcare

Access to resources Recommend Favorite

Effect of enterohaemorrhagic Escherichia coli O157:H7‐specific enterohaemolysin on interleukin‐1β production differs between human and mouse macrophages due to the different sensitivity of NLRP3 activation

By  

IMMUNOLOGY, Vol. 145, Iss. 2, 2015-06 ,pp. : 258-267

John Wiley & Sons Inc

Access to resources Recommend Favorite